Oligosaccharides expressed an MUC1 produced by pancreatic and colon tumor cell lines

被引:185
作者
Burdick, MD
Harris, A
Reid, CJ
Iwamura, T
Hollingsworth, MA
机构
[1] UNIV NEBRASKA,MED CTR,EPPLEY INST RES CANC & ALLIED DIS,OMAHA,NE 68198
[2] UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOL MED,OXFORD OX3 9DU,ENGLAND
[3] MIYAZAKI MED COLL,DEPT SURG 1,MIYAZAKI 88916,JAPAN
关键词
D O I
10.1074/jbc.272.39.24198
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MUC1 is expressed at the apical surface of ductal epithelia of tissues, including breast, pancreas, airway, and the gastrointestinal tract, where its functions include lubrication and protection of the epithelia, In addition, roles for MUC1 have been suggested in both adhesive and antiadhesive properties of tumor cells, and extensive O-glycosylation of the MUC1 tandem repeat domain may contribute to these functions. Little information is available on the specific O-glycosylation of MUC1. One problem in identifying different MUC1 glycoforms has been that monoclonal antibodies raised against the MUC1 core protein recognize epitopes in the tandem repeat domain, which is often glycosylated to an extent that obscures these epitopes, We developed an epitope-tagged form of MUC1 that allowed the detection of multiple MUC1 glycoforms and established the presence of a number of important blood group and tumor-associated carbohydrate antigens on MUC1 expressed by two pancreatic tumor cell lines (Panc-1 and S2-013) and two colon tumor cell Lines (Caco-2 and HT-29). Antigens detected include sialyl-Lewis(a), sialyl-Lewis(c), sialyl-Lewis(x), and sialyl-Tn.
引用
收藏
页码:24198 / 24202
页数:5
相关论文
共 33 条
  • [1] BATRA SK, 1991, J CELL SCI, V100, P841
  • [2] BATRA SK, 1992, INT J PANCREATOL, V12, P271
  • [3] THE PRODUCT OF THE HUMAN MUC1 GENE WHEN SECRETED BY MOUSE CELLS TRANSFECTED WITH THE FULL-LENGTH CDNA LACKS THE CYTOPLASMIC TAIL
    BOSHELL, M
    LALANI, EN
    PEMBERTON, L
    BURCHELL, J
    GENDLER, S
    TAYLORPAPADIMITRIOU, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (01) : 1 - 8
  • [4] BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730
  • [5] MECHANISMS UNDERLYING ABERRANT GLYCOSYLATION OF MUC1 MUCIN IN BREAST-CANCER CELLS
    BROCKHAUSEN, I
    YANG, JM
    BURCHELL, J
    WHITEHOUSE, C
    TAYLORPAPADIMITRIOU, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 233 (02): : 607 - 617
  • [6] INHIBITION OF MUCIN SYNTHESIS BY BENZYL-ALPHA-GALNAC IN KATO-III GASTRIC-CANCER AND CACO-2 COLON-CANCER CELLS
    BYRD, JC
    DAHIYA, R
    HUANG, J
    KIM, YS
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (09) : 1498 - 1505
  • [7] GENDLER SJ, 1990, J BIOL CHEM, V265, P15286
  • [8] MUCIN GENES AND THE PROTEINS THEY ENCODE - STRUCTURE, DIVERSITY, AND REGULATION
    GUM, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1992, 7 (06) : 557 - 564
  • [9] A HUMAN BETA-ACTIN EXPRESSION VECTOR SYSTEM DIRECTS HIGH-LEVEL ACCUMULATION OF ANTISENSE TRANSCRIPTS
    GUNNING, P
    LEAVITT, J
    MUSCAT, G
    NG, SY
    KEDES, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (14) : 4831 - 4835
  • [10] MUC1 glycoforms in breast cancer - Cell line T47D as a model for carcinoma-associated alterations of O-glycosylation
    Hanisch, FG
    Stadie, TRE
    Deutzmann, F
    PeterKatalinic, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (01): : 318 - 327